Agilon Health Is Maintained at In-Line by Evercore ISI Group
Evercore ISI Group Maintains In-Line on Agilon Health, Lowers Price Target to $4
Evercore Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $4
Agilon Health Sees Double Downgrade at BoA on 'Deteriorating' MA Environment
BofA Securities Downgrades Agilon Health(AGL.US) to Sell Rating, Announces Target Price $3
Agilon Health Analyst Ratings
B of A Securities Downgrades Agilon Health to Underperform, Announces $3 Price Target
Jefferies Maintains Agilon Health(AGL.US) With Hold Rating, Cuts Target Price to $4.75
Maintaining Equilibrium: Hold Rating on Agilon Health Amidst Growth and Risk
Analysts Offer Insights on Healthcare Companies: Agilon Health (AGL) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)
Agilon Health Analyst Ratings
Deutsche Bank Maintains Hold on Agilon Health, Lowers Price Target to $4
Agilon Health Holds Steady: A Balanced Analysis of Performance and Uncertainties
Agilon Health Analyst Ratings
Benchmark Reiterates Buy on Agilon Health, Maintains $9 Price Target
Agilon Health Price Target Maintained With a $8.00/Share by RBC Capital
Agilon Health Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Agilon Health (AGL)
Agilon Health (AGL) Gets a Hold From Evercore ISI
RBC Capital Reaffirms Their Buy Rating on Agilon Health (AGL)